Skip to NavigationSkip to content

News

0
Potential milestone payments could make the deal worth up to $1.5 billion
0
Bayer’s Eylea (aflibercept) has been adjudged to be more clinically effective than existing first-line treatment laser photocoagulation
0
CEO Heather Bresch has received a salary increase of 671% while the cost of EpiPen has risen 400%
0
Pfizer’s leukaemia drug Bosulif (bosutinib) and Eli Lilly’s lung cancer treatment Alimta (pemetrexed) have been deemed cost-effective following...

Features

It made headlines last week as a judge ruled that the treatment could be funded by the NHS, but some have labelled it simply a “lifestyle drug”....